FDA Extends Pause On Non-mission-critical Domestic Surveillance Inspections To February 4 – Medical Products Supply Chain Week In Review - Food, Drugs, Healthcare, Life Sciences
Previously, Robert Califf previewed his priorities, if confirmed, to the Senate HELP Committee.